Documente Academic
Documente Profesional
Documente Cultură
Pty Ltd
This training program is copyright to SeerPharma Pty Ltd and may not be modified, reproduced, sold, loaned, hired or traded in any
form without the express written permission of SeerPharma Pty Limited, SeerPharma (Singapore) Pte Ltd or its subsidiaries.
Module Content
This module covers the
requirements for
contamination control in
non-sterile & sterile
manufacturing.
It identifies potential
sources of contamination
and issues regarding
effective control.
Module MP6405-1 Ver 01
Module Outcome
On completion of this module, you will be able to:
Define Contamination Control and explain
why it is critical
List the major sources of physical, chemical and
microbiological contamination
State regulations pertaining to contamination
control
Explain the systems or procedures required
for control of each type of contamination
Module MP6405-1 Ver 01
Principle
The holder of a manufacturing authorization
must manufacture medicinal products so as
to ensure that they are fit for their intended
use, comply with the requirements of the
marketing authorization and do not place
patients at risk due to inadequate safety,
quality or efficacy.
PIC/S Guide to GMP Chapter 1 Quality Management- Principle
Principle
It is manifestly impossible to include in each
monograph a test for every impurity,
contaminant, or adulterant that might be
present, including microbial contamination.
These may arise form a change in the source of
material or from a change in the processing, or
may be introduced from extraneous sources.
USP/NF General Notices, Foreign Substances and Impurities
What is Contamination?
Contamination is the act of contaminating or
polluting; including either intentionally or
accidentally unwanted and potentially
dangerous substances or factors
Contamination is also the state of being
contaminated
Some Statistics
Drug Recall Data (a typical year)
35
Potency
30
Dissolution
25
Other
20
Contamination
15
Labelling
10
NDA Compliance
5
0
Manuf./Testing
Recalls in 2003
10
11
Reasons/Motives
Accidental:
One off
Systematic
Deliberate:
Criminal/Retaliation
Substitution
12
Types of Contamination
Physical, e.g.
Dust
Fibers
Metallic or plastic particles
Chemical, e.g.
Cross contamination
Microbiological, e.g.
Bacteria, endotoxins
Fungi & Yeast
Viruses
Module MP6405-1 Ver 01
13
Group Activity
In groups of 3 to 6
Time allocation 25 minutes
Prepare response to question as dot points.
Try and identify some of the sources of
contamination for the contaminants
mentioned in the previous slide.
Any ideas on how to control those
contaminants?
Module MP6405-1 Ver 01
14
Equipment
Material of construction
Cleanability
Personnel
Hygienic behaviour
Gowning practices
Inadequate training: GMP, procedures and on the job
15
16
GMP Requirements
Premises and equipment must be located,
designed, constructed, adapted and
maintained to suit the operations to be carried
out. Their layout and design must aim to
minimise the risk of errors and permit
effective cleaning and maintenance in
order to avoid contamination, build up of
dust or dirt and, in general, any adverse
effect on the quality of products.
PIC/S GMP Chapter 3- Principle
17
18
Facility Cleaning
Premises should be carefully maintained,
ensuring that repair and maintenance
operations do not present any hazard to the
quality of products.
They should be cleaned and, where
applicable, disinfected according to detailed
written procedures
PIC/S Code of GMP- Clause 3.2 (part)
19
Exercise
In groups of 3 to 6
Time allocation 15 minutes
Prepare response to question as
dot points.
Using EU GMP Chapter 5
What controls should be in place
place to prevent contamination from
the buildings / facility themselves?
Module MP6405-1 Ver 01
20
10
Equipment
Equipment should be designed, located and
maintained to suit its intended purpose.
The following need to be considered to prevent
contamination:
Choice of material of construction & lubricants
Repair and maintenance operations
Ease and thoroughness of cleaning
Choice of washing and cleaning equipment
Time limitations between use and cleaning, and
cleaning and use
Storage of equipment post cleaning
Module MP6405-1 Ver 01
21
Exercise
In groups of 3 to 6
Time allocation 15 minutes
Prepare response to question as dot
points.
22
11
Personnel
Detailed hygiene programs should be
established and adapted to the different
needs within the factory.
Hygiene programs should be promoted by
management and widely discussed during
training sessions
PIC/S GMP- Clause 2.13 (part)
23
Personal Hygiene
Medical examination upon recruitment
No infectious diseases or open lesions on exposed
surface of the body
Protective garments
No eating, drinking, chewing or smoking, or the storage of
food, drink, smoking materials or personal medication
In general, any unhygienic practice within the
manufacturing areas or in any other area where the
product might be adversely affected, should be
forbidden.
No direct contact with exposed product or equipment that
comes into contact with the products
Hand-washing facilities
PIC/S GMP- Clause 2.14 - 2.19 (part)
Module MP6405-1 Ver 01
24
12
25
Exercise
In groups of 3 to 6
Time allocation 15 minutes
Prepare response to question as dot
points.
26
13
Sampling Procedures
There should be written procedures for sampling,
which include:
the person(s) authorised to take samples,
the methods and equipment to be used,
the amounts to be taken, and
any precautions to be observed to avoid
contamination of the material or any deterioration
in its quality
PIC/S GMP- Sampling -Clause 4.22
27
28
14
29
Cross-Contamination in Production
Contamination of a starting material or of a product by
another material or product must be avoided. This risk of
accidental cross contamination arises from the
uncontrolled release of dust, gases, vapours, sprays
or organisms from materials and products in process,
from residues on equipment, and from operators
clothing.
The significance of this risk varies with the type of
contaminant and the product being contaminated..
Products in which contamination is likely to be most
significant are those administered by injection, those
given in large doses and/or over a long period of time.
PIC/S GMP- Prevention of cross-contamination in production -Clause 5.18
Module MP6405-1 Ver 01
30
15
Controlling Cross-Contamination
Production in segregated areas or by
campaign followed by appropriate cleaning
Appropriate air locks and air extraction
Minimizing risk of contamination caused by
recirculation or re-entry of untreated or
insufficiently treated air
Keeping protective clothing inside areas
where products with special risk of cross
contamination are processed
31
Controlling Cross-Contamination
Processing Operations
The following should be in place:
Line clearance prior to start
In-process and environmental controls
Acceptable ranges for expected yields and
review of actual yields
Time limits on manufacturing
Maintenance handover procedures
Chronologically completed log books and
records
Module MP6405-1 Ver 01
32
16
Controlling Cross-Contamination
Packaging Operations
When setting up a program for the packaging
operations, particular attention should be
given to minimizing the risk of crosscontamination, mix-ups or substitutions.
Different products should not be packaged in
close proximity unless there is physical
segregation.
PIC/S GMP- Packaging Operations -Clause 5.44
33
Systems to minimise/reduce
contamination
Written Programs have to be in place to
ensure that steps towards minimizing /
reducing contamination and that they are
being followed:
Plans
Procedures
Records
34
17
Quality System
file://localhost/Users/
raymondcollyer/Desktop/Module 3
MP6405 Cross Contamination/
MP6405 Contamination Control/
MP6405-1 Introduction/Not for
printing/10 IER Ben Venue Nov
2011.pdf
35
General Concepts
Quality of the Product
Achieving characteristics of the product that are designed
to ensure the required levels of safety and effectiveness
Quality by Design and Product Development
Designing and developing manufacturing processes to
consistently ensure the predefined quality at the end of the
manufacturing process
Risk Management and Risk Assessment
Which contaminants are of concern?
Corrective and Preventive Action (CAPA)
Change Control
How will a change in process, a solvent, a cleaning agent,
impact the performance of a product?
The Quality Unit and Internal Audits
Module MP6405-1 Ver 01
36
18
37
38
19
Ongoing Monitoring
Monitoring Programs
39
40
20
Glossary
Containment The action of confining a biological
agent or other entity within a defined space.
Contained area An area constructed and operated in
such a manner (and equipped with appropriate air
handling and filtration) so as to prevent
contamination of the external environment by
biological agents from within the area.
Cross-contamination Contamination of a starting
material or of a product with another material or
product.
41
References
The PIC/S Guide to Good Manufacturing Practice for
Medicinal Products.
USP/NF: General Notices chapter
FDA Guidance for Industry: Quality Systems
Approach to Pharmaceutical CGMP Regulations
The Gold Sheet: Vol. 38, No.3, March 2004- Drug
Recall Data
42
21
- www.medicinesaustralia.com.au
43
22